May 2008
Volume 49, Issue 13
Jump To...
Free
ARVO Annual Meeting Abstract  |   May 2008
Agreement for Detecting Glaucomatous Change Using the GDx VCC Scanning Laser Polarimeter, Standard Automated Perimetry and Stereophotograph Assessment
L. M. Alencar; G. Vizzeri; R. N. Weinreb; C. Bowd; L. M. Zangwill; P. A. Sample; F. A. Medeiros
Author Affiliations & Notes
  • L. M. Alencar
    Hamilton Glaucoma Center, University of California San Diego, La Jolla, California
    Department of Ophthalmology, University of São Paulo, São Paulo, Brazil
  • G. Vizzeri
    Hamilton Glaucoma Center, University of California San Diego, La Jolla, California
  • R. N. Weinreb
    Hamilton Glaucoma Center, University of California San Diego, La Jolla, California
  • C. Bowd
    Hamilton Glaucoma Center, University of California San Diego, La Jolla, California
  • L. M. Zangwill
    Hamilton Glaucoma Center, University of California San Diego, La Jolla, California
  • P. A. Sample
    Hamilton Glaucoma Center, University of California San Diego, La Jolla, California
  • F. A. Medeiros
    Hamilton Glaucoma Center, University of California San Diego, La Jolla, California
    Department of Ophthalmology, University of São Paulo, São Paulo, Brazil
  • Footnotes
    Commercial Relationships  L.M. Alencar, None; G. Vizzeri, None; R.N. Weinreb, Heidelberg Engineering, F; Carl-Zeiss Meditec, F; Carl-Zeiss Meditec, C; C. Bowd, Lace Elettronica, F; L.M. Zangwill, Heidelberg Engineering, F; Carl Zeiss Meditec, F; Optovue, F; Allergan, F; P.A. Sample, Carl-Zeiss Meditec, F; Welch Allyn, F; Haag Streit, F; F.A. Medeiros, Carl Zeiss Meditec, R; Heidelberg Engineering, F; Carl Zeiss Meditec, F.
  • Footnotes
    Support  Supported in part by NIH EY008208 (PAS), NHI EY011008 (LMZ), Participant incentive grants in the form of glaucoma medication at no cost (Alcon Laboratories Inc., Allergan, Pfizer Inc., SANTEN Inc.).
Investigative Ophthalmology & Visual Science May 2008, Vol.49, 741. doi:
  • Views
  • Share
  • Tools
    • Alerts
      User Alerts
      You are adding an alert for:
      Agreement for Detecting Glaucomatous Change Using the GDx VCC Scanning Laser Polarimeter, Standard Automated Perimetry and Stereophotograph Assessment
      You will receive an email whenever this article is corrected, updated, or cited in the literature. You can manage this and all other alerts in My Account
      The alert will be sent to:
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation
      Citation

      L. M. Alencar, G. Vizzeri, R. N. Weinreb, C. Bowd, L. M. Zangwill, P. A. Sample, F. A. Medeiros; Agreement for Detecting Glaucomatous Change Using the GDx VCC Scanning Laser Polarimeter, Standard Automated Perimetry and Stereophotograph Assessment. Invest. Ophthalmol. Vis. Sci. 2008;49(13):741.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

      ×
    • Get Permissions
  • Supplements
Abstract
 
Purpose:
 

To evaluate the ability of Scanning Laser Polarimetry (GDx VCC) nerve fiber layer analysis in detecting glaucomatous progression, and to compare with Standard Automated Perimetry (SITA SAP) and stereophotograph assessment.

 
Methods:
 

This study enrolled a cohort of glaucoma patients and glaucoma suspects selected from the Diagnostic Innovations in Glaucoma Study (DIGS), who had ≥ 3 good quality GDx exams, ≥ 1 year of follow-up, routine visual fields (VF) and stereophotographs. In total, 1196 examinations were obtained in 249 eyes of 145 individuals during an average GDx follow-up time of 48.7 ± 9.8 months. Change was assessed comparing each visit’s parameters with the baseline. We defined progression when the change in GDx parameters’ values was above the expected long-term variability. Long-term variability estimates (95% specificity) were obtained from the analysis of a separate group of 31 patients suspected of having glaucoma followed untreated for an average of 9.1 ± 3.2 years and who did not develop any evidence of visual field loss or progressive optic nerve damage. Progression by VF was assessed using the Glaucoma Progression Analysis (GPA); and by stereophotographs was assessed comparing the latest photo with the baseline.

 
Results:
 

Nine eyes progressed only by VF, 14 eyes only by optic disc changes in the stereophotographs, and 6 eyes by both methods. From these 29 eyes, 8 had progression in at least one GDx parameter. However, 52 eyes showed progression with at least one GDx parameter but no changes in VF or photographs.

 
Conclusions:
 

RNFL longitudinal analysis with the GDx detects more change over time than SAP or stereophotograph assessment. These results might suggest increased sensitivity compared to SAP and photograph assessment, however, further follow-up is necessary to confirm these findings. Poor agreement among the three methods suggests that these techniques might be evaluating different features of glaucoma progression.  

Image not available
View OriginalDownload Slide
Image not available
View OriginalDownload Slide

 
Keywords: clinical (human) or epidemiologic studies: risk factor assessment • imaging/image analysis: clinical • optic disc 
© 2008, The Association for Research in Vision and Ophthalmology, Inc., all rights reserved. Permission to republish any abstract or part of an abstract in any form must be obtained in writing from the ARVO Office prior to publication.
Copyright © 2025 Association for Research in Vision and Ophthalmology.
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.Accept